Human Microbiome Drug Targets: Modern Approaches in Disease Management
Editat de Genevieve Dable-Tupas, Rohini Karunakaran, Peter Paul C Lim, Maria Catherine B Oteroen Limba Engleză Paperback – 25 oct 2024
- Provides readers with background information on the human microbiome, its evolution, and current understanding
- Includes chapters dedicated to the importance of the human microbiome as "drugs" and as drug targets
- Serves as a guide to drug developers working in pharma, biotech, and academia, bringing together the latest research on the topic
Preț: 1050.89 lei
Preț vechi: 1329.45 lei
-21% Nou
Puncte Express: 1576
Preț estimativ în valută:
201.10€ • 211.56$ • 166.50£
201.10€ • 211.56$ • 166.50£
Carte disponibilă
Livrare economică 17-31 decembrie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443154355
ISBN-10: 044315435X
Pagini: 350
Dimensiuni: 152 x 229 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 044315435X
Pagini: 350
Dimensiuni: 152 x 229 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
Cuprins
Part One: Foundational Information 1. Tracing the History of Microbiome Evolution 2. The Human Microbiome: An Overview 3. The GUT Microbiome 4. The Microbiome and One Health Approach 5. Overview of Human Microbiome and Drug Discovery Part Two: Human Microbiome in Health and Disease 6. Human Microbiome and Nutrition 7. Human Microbiome and Mental Health 8. Human Microbiome and Diabetes 9. Human Microbiome and Cancer and Cancer Therapy 10. Human Microbiome, Obesity and Cardiovascular Diseases 11. Human Microbiome and Respiratory Diseases 12. Human Microbiome and Liver Diseases 13. Human Microbiome and Neuro-Developmental Disorders 14. Human Microbiome and Inflammatory Diseases Part Three: Microbiome and Drug Discovery 15. The Human Microbiome as Drug Targets 16. Microbiome-Based Therapeutics (Including Probiotics, Prebiotics and Symbiotics) 17. Microbiome Metabolite Based Therapies 18. Role of Nanotechnology in Microbiome Drug Development 19. Microbiome-Based Therapies on Trial